Incision-site infiltration with local anesthetics prevents pain on incision site, but pain relief is limited to the first few postoperative hours. Dexamethasone as an adjuvant to local infiltration successfully achieves better postoperative pain relief; however, this has not been studied in craniotomy patients yet. This is a prospective, single-center, blinded, randomized, controlled trial included patients aged between 18 and 64 years, ASA physical status of I-II, scheduled for elective supratentorial tumor craniotomy under general anesthesia. We screened patients for enrollment from April 4, 2019 through August 15, 2019. The final study visit of the last patient was conducted on February 13, 2020. We randomly assigned eligible participants (11) to either the dexamethasone group who received incision-site infiltration of 0.5% ropivacaine plus 0.033% dexamethasone (N=70) or the control group who received 0.5% ropivacaine alone (N=70). Primary outcome was the cumulative sufentanil consumption (μg) within 48 hours postoperatively. Primary analysis was performed based on the modified intention-to-treat (MITT) principle. Baseline characteristics were similar between the groups (p>0.05). Sufentanil consumption during the first 48 hours postoperatively was 29.0 (10.7) μg in the dexamethasone group and 38.3 (13.7) μg in the control group (mean difference -9.3, 95% CI -13.4 to -5.1; p<0.001). There was no serious adverse effect directly associated with incision-site infiltration or local dexamethasone use. The addition of dexamethasone to pre-emptive incision-site infiltration with the local anesthetic can reduce about 27% of opioids consumption and the postoperative pain scores within 72 hours after craniotomy. ClinicalTrials.Gov (NCT03618264). ClinicalTrials.Gov (NCT03618264). Cognitive impairment is a complication that most frequently happens in patients with chronic neuropathic pain and has limited effective therapy. The aim of this study was to explore the effects of curcumin on the cognitive deficit in rats with peripheral nerve injury induced-neuropathic pain. The neuropathic pain rat model was constructed using chronic constriction injury (CCI). The curcumin (60 mg/kg) or vehicle was intraperitoneally administered once a day, beginning at 14th day after surgery and continued for 14 consecutive days. The nociceptive threshold tests were measured by paw mechanical withdraw threshold (PMWT) and paw thermal withdrawal latency (PTWL), while the spatial memory abilities were evaluated by the Morris water maze test. The mean counts of bromodeoxyuridine (Brdu)/neuronal nuclei (NeuN) as well as Brdu/doublecortin (DCX) co-labeled cells were used to evaluate neurogenesis in the dentate gyrus of hippocampus. The ultrastructure of the synapse in hippocampal region was visualized usinghe cognitive impairment restoration under prolonged neuropathic pain condition. The aim of this study was to determine the effectiveness of botulinum toxin administration in patients who consulted the otolaryngology clinic with secondary otalgia caused by bruxism. Botulinum toxin can be applied to the hypertrophic muscles in patients who suffer from facial asymmetry even though they do not experience pain. Injection intervals and the condition of the muscles should be monitored as botulinum toxin applications to the muscles may result in decreased muscle strength and chewing difficulties. This prospective study was conducted with bruxism patients at Private Kesan Hospital otorhinolaryngology outpatient clinic between August 2019 and December 2019. The diagnosis was based on the anamnesis and physical examination of the patient. The Visual Analogue Scale was used to evaluate patients' pain levels throughout the treatment. A total of 37 patients, between 19 and 51 years old, 22 (59.46%) females and 15 (40.54%) males, who consulted to the otolaryngology clinic in Private Kesan Hospi, chewing training, neck and facial muscle relaxation techniques, psychological support, and dental splint applications. infection is an important cause of peptic ulcer disease and gastric cancer. Current knowledge regarding epidemiology of infection in military personnel has insufficiently been updated. This cross-sectional study aimed to estimate the prevalence of infection in military personnel and to compare the prevalences in military and civilian groups. We retrospectively enrolled the subjects who underwent C-urea breath tests at the Department of Gastroenterology of the General Hospital of Northern Theater Command between January 2017 and July 2020. Subjects were divided into military and civilian groups. infection and major endoscopic findings were reviewed. Overall, 23,496 subjects were eligible, including 2282 subjects in the military group and 21,214 subjects in the civilian group. In the overall analysis, the prevalence of infection was not significantly different between military and civilian groups (33.9% versus 34.4%, =0.592). In the population aged 17-25 years, the prevalence of infection was significantly higher in the military group than in the civilian group (35.6% versus 25.9%, =0.001). Both C-UBT and endoscopy were performed in 547 inpatients, including 83 military inpatients and 464 civilian inpatients. There was a significantly higher prevalence of in inpatients with peptic ulcer and/or gastric cancer than in those without (65.5% versus 41.4%, =0.001). Among the adolescent population, infection may be more common in military personnel as compared to the civilians. Well-designed prospective studies should be required to validate such a high prevalence and to explain its potential causes. Among the adolescent population, H. pylori infection may be more common in military personnel as compared to the civilians. Well-designed prospective studies should be required to validate such a high prevalence and to explain its potential causes. COVID-19, which causes severe acute respiratory syndrome, is spreading rapidly across the world, and the severity of this pandemic is rising in Ethiopia. The main objective of the study was to analyze the trend and forecast the spread of COVID-19 and to develop an appropriate statistical forecast model. Data on the daily spread between 13 March, 2020 and 31 August 2020 were collected for the development of the autoregressive integrated moving average (ARIMA) model. Stationarity testing, parameter testing and model diagnosis were performed. https://www.selleckchem.com/products/tp-0903.html In addition, candidate models were obtained using autocorrelation function (ACF) and partial autocorrelation functions (PACF). Finally, the fitting, selection and prediction accuracy of the ARIMA models was evaluated using the RMSE and MAPE model selection criteria. A total of 51,910 confirmed COVID-19 cases were reported from 13 March to 31 August 2020. The total recovered and death rates as of 31 August 2020 were 37.2% and 1.57%, respectively, with a high level of increase after the mid of August, 2020.